NEW YORK (AP) — No ex-president had a more prolific and diverse publishing career than Jimmy Carter . His more than two dozen books included nonfiction, poetry, fiction, religious meditations and a children’s story. His memoir “An Hour Before Daylight” was a Pulitzer Prize finalist in 2002, while his 2006 best-seller “Palestine: Peace Not Apartheid” stirred a fierce debate by likening Israel’s policies in the West Bank to the brutal South African system of racial segregation. And just before his 100th birthday, the Dayton Literary Peace Prize Foundation honored him with a lifetime achievement award for how he wielded “the power of the written word to foster peace, social justice, and global understanding.” In one recent work, “A Full Life,” Carter observed that he “enjoyed writing” and that his books “provided a much-needed source of income.” But some projects were easier than others. “Everything to Gain,” a 1987 collaboration with his wife, Rosalynn, turned into the “worst threat we ever experienced in our marriage,” an intractable standoff for the facilitator of the Camp David accords and winner of the Nobel Peace Prize. According to Carter, Rosalynn was a meticulous author who considered “the resulting sentences as though they have come down from Mount Sinai, carved into stone.” Their memories differed on various events and they fell into “constant arguments.” They were ready to abandon the book and return the advance, until their editor persuaded them to simply divide any disputed passages between them. “In the book, each of these paragraphs is identified by a ‘J’ or an ‘R,’ and our marriage survived,” he wrote. Here is a partial list of books by Carter: “Keeping Faith: Memoirs of a President” “The Blood of Abraham: Insights into the Middle East” (With Rosalynn Carter) “Everything to Gain: Making the Most of the Rest of Your Life” “An Outdoor Journal: Adventures and Reflections” “Turning Point: A Candidate, a State, and a Nation Come of Age” “Always a Reckoning, and Other Poems” (With daughter Amy Carter) “The Little Baby Snoogle-Fleejer” “Living Faith” “The Virtues of Aging” “An Hour Before Daylight: Memories of a Rural Boyhood” “Christmas in Plains: Memories” “The Hornet’s Nest: A Novel of the Revolutionary War” “Our Endangered Values: America’s Moral Crisis” “Faith & Freedom: The Christian Challenge for the World” “Palestine: Peace Not Apartheid” “A Remarkable Mother” “Beyond the White House” “We Can Have Peace in the Holy Land: A Plan That Will Work” “White House Diary” “NIV Lessons from Life Bible: Personal Reflections with Jimmy Carter” “A Call to Action: Women, Religion, Violence, and Power” “A Full Life: Reflections at Ninety”
San Francisco 49ers head coach Kyle Shanahan spoke with reporters after Saturday's practice as the team prepares for its Week 17 matchup against the Detroit Lions. Here's everything he said. Transcript provided by the San Francisco 49ers Communications staff. Opening comments: "Alright, injuries for the game: [OL] Spencer Burford will be out, [LB Dre] Greenlaw will be out, [OL] Aaron Banks, out, [DL] Robert Beal [Jr.], out, [S] Ji'Ayir Brown, questionable, [OL] Colton McKivitz, questionable, [LB] Tatum Bethune, questionable, [CB] Charvarius Ward, questionable. Go ahead." Is Charvarius Ward personal? "Yes." Any good news? "Yeah. Stuff I can't totally share. I haven't talked to him about it, so we'll keep it personal. But, nothing bad happened." Do you expect Banks and Greenlaw to be on IR before the game starts? "Banks will." What's the biggest challenge the Lions pose to your team? "Just how good they are in all phases. Their offense, everyone is well aware of how good they've been these last couple years. Anytime you have an O-Line as good as them, the running back as good as them, you can control the ball which takes a lot of pressure off the quarterback and on pass protections. And then when you have a quarterback as good as him with how accurate he is, with that O-Line and those receivers, they're pretty lethal there. And then the defense, I know they've battled through a lot of injuries, but their secondary is as good as there is. They've been able to stay healthy there. They've lost one big one, but they have some depth there. And what they can create with their pressures and things like that because of their man coverage makes them very tough to be consistent with. They put a lot of pressure on you where they know how to stop the run with their scheme. And then you're never going to get really many freebies. You've got to beat man coverage, you've got to beat pressures, which is going to always be hit or miss. But when you do that with an offense that's so automatic it puts pressure on both sides of the ball to not let them lap you. So, you've got to be consistent, got to get turnovers." Is there anything you can point to for the dearth of takeaways over the last several games? "Yeah. Usually when you're flying around you're eventually going to get some more takeaways than we have. I think one thing that's been bad is we've dropped some that have been given to us, so we've missed a couple opportunities. In games when you don't stop the run very well and you don't make guys throw the ball a lot, 80-percent of the turnovers in the league come on pass plays. So, you need to stop the run and get guys to throw the ball a lot more and then you'll get more opportunities at that. And so, I think when we have had our opportunities, we've missed them. And anytime teams can stay balanced versus us you're going to get less of those opportunities." RB Isaac Guerendo is not on the injury report. How did he kind of get through the week? "Yeah, it was good to have him back. We had a full-speed practice yesterday and he looked good. So, no holdbacks, he's good to go." What's your biggest challenge with putting together this offensive line with all the new pieces in there? "Just that. Having three guys up who were on other team's practice squads last week. The continuity's obviously not there and just them not being in the building with verbiage and things like that, it's a big challenge. They've done a good job of working, getting in here the day before Christmas, working on Christmas, trying to catch up and do that stuff. And they've had a solid week of practice. Still got more time until the game and those guys will be working as much mentally to get ready, but anytime you're new and you haven't been out there much, it's always a challenge." Is this your biggest turnover on offensive line that you've dealt with in your coaching career? "Probably. Biggest one I can remember." Does that fall on OL Jake Brendel or QB Brock Purdy to kind of help these guys line up, I guess, in the midst of the game rather? "The good thing is, if O-Linemen mess up lining up, then we have issues. Because they don't move, at least until the snap starts. But no, that's, helping communicate is a big deal, but sometimes you communicate and that language doesn't always come right away. You try to keep it simple for them, try to categorize stuff in groups, and the guys next to them just, they try to communicate as much as possible and you try to help him out." OL Charlie Heck having worked with Houston Texans offensive coordinator Bobby Slowik, does that help you a bit? "Yeah. He has the most familiarity with some terminology. So anytime there's some crossover, different O-Line coaches, you go to different places, you change your words and stuff, but a lot, when it comes from the same foundation you have some familiarity and so it's not completely starting a new language. That always helps." What's your assessment of Detroit Lions offensive coordinator Ben Johnson as an offensive coordinator? "I don't know him, but I've really respected what he's done here the last few years. I know people who've worked with him. I know [run game coordinator/offensive line coach] Chris [Foerster], [tight ends coach Brian] Fleury, those guys worked with him down in Miami, talked about him as a dude, which he seems like an awesome guy. But I really love how he's ran the ball and the stuff he's done off of it and really taken advantage of his personnel really well." When you were watching replays of the NFC Championship Game this week, were there feel-good vibes or were there mixed feelings that you wish you had those players available this week? "No. It was, when you watch a game like that, it was feel-good vibes to a degree. You watch the first half and you get frustrated, but you know how it's going to end so you don't get too frustrated. There were good things to coach off of. You can see some mistakes, big mistakes there in the first half and it's cool to show guys overcome them and how you do it. So, there were a lot of really good drives in that game. There were some big plays in the game, but just kind of the toughness that we played with in the second half, really showing guys truly what it takes to win when it's not just a guy making a, there were some really unbelievable plays like [WR Brandon Aiyuk] B.A. on the tip down the field and stuff like that. But besides that, some big scrambles by Brock, but it was some real hard-nosed football that got us back in that game and doing it the old-fashioned way. And it was cool to watch that. We watched a lot of it yesterday, just talking about run game and things like that." We've seen B.A. around here a little bit. How is he doing? Everything on progress? "Yeah, he's plugging along with that. The rehab guys I don't see too much of. They come in early in the morning and they're usually out of here before we get off the practice field. But he went to L.A. for surgery, did the rehab there for a while, but he's been back here like the last month or so going through his process, working hard. It's a long process, but he's on track." You've talked a lot about the year TE George Kittle has had, but in a year like this when you have so many young guys playing, how important is it to have someone who is kind of consistently maintaining the standard to show those guys what it looks like even if the season isn't where you want it? "Oh, I think it's always important. You don't just say a standard. It takes a while to be that standard. And that's from work we've put in here over the years and having the right guys who've done that and guys who have battled throughout this year they get to see every day. Especially when you go through a long season like this, seeing guys like Kittle [LB], Fred [Warner], [DL Nick] Bosa getting back and [WR] Deebo [Samuel Sr.] like those guys, working through all this, still practicing hard and doing everything they can. That's extremely important. All you are, is your life experiences and this is a lot of people's first year and you need to see things done the right way no matter how your season's going." Has Detroit Lions QB Jared Goff improved since his days with the Rams or is he the same quarterback in a good situation? "I think it's hard for any quarterback to be successful if they're not in a good situation. But I think Goff was unbelievable with the Rams. Their Super Bowl year, I thought he was a borderline MVP player. I know not every year was like that for him just statistically and stuff. I think the following years weren't quite as good, but when his team's real good around him, he is as good as any quarterback in this league. So, he was a real hard guy to beat in L.A. and the way he's been playing with Detroit, I almost want to say better, but that's how good he was earlier too. So, it was a hell of a rebound for him and I'm happy to see him doing it." Former 49ers RB Ricky Watters didn't make the cut to 15 in the Hall of Fame. You were around the team in '94. What do you remember about him, specifically about what impressed you about him? "How good he was out of the backfield in the pass game. I was only in middle school, so I can't act like I really knew strategically what was going on. But he was a really cool player. I loved talking to him and hanging out with him up in Rockland at training camp. I think when I got here, he hadn't played yet, so I didn't know who he was, just only knew guys who had played and stuff as a sixth grader. But I remember always asking, who the hell is this guy? He is cool, he seems really good on the practice field. And then he became the starter that year and had a hell of a year and ended up having a hell of a career." I realize the season's not done, but your overall assessment of defensive coordinator Nick Sorensen? Obviously there have been challenges with the personnel and what he has to work with. But with his first year, how do you think he's fared? "No different than how I've answered that the last few weeks. I think Nick has done a good job as a coach. No one's happy with our results by any means. I think he's been thrown in a number of situations that I think will make him better going forward. I've watched him adjust to a bunch of different situations, kind of be in a couple situations on a couple games when there wasn't much of an answer, and he still had to try to find one. So, I think this year was good for him. I know he is going to be a good coach and better for it going forward." The Lions have had 19 guys on Injured Reserve, similar to the injury level here. How have they been able to kind of stay up to the standards of winning games? "Just me going off these five days of watching them, I know all the injuries, you see it on the reports and especially losing their pass rushers and their D-Linemen. But I think the biggest thing is it's hit them the most in certain areas on defense. But when you play as much man coverage as they do and blitz as much, that's going to be predicated on your secondary. I think they improved that a ton this year with their draft picks, with some free agents they brought in, even their draft picks from two years ago, their safety getting healthy, also. So, the areas that they excel in they've been able to maintain the top of their talent there and it does give them some weaknesses in other places, but that combined with their offensive horsepower and things like that, it's made it hard for a lot of teams to expose it. They've done a hell of a job with it, so huge credit to them for it." This article first appeared on 49ers Webzone and was syndicated with permission.
Supreme Court seems likely to uphold Tennessee's ban on treatments for transgender minors
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Texas Supreme Court overturns ruling that state Attorney General Ken Paxton testify in lawsuit
Last men standing: Aussie lower order fires after Bumrah show, hosts lead by 333 going into fInal day at MCG
Alexander: Is diminished USC-UCLA game another reminder of what we’ve lost?
US lawmakers voted Wednesday after fraught negotiations to move forward with a contentious 2025 defense budget that raises troops' pay but blocks funding of gender-affirming care for some transgender children of service members. The centerpiece of the $884 billion National Defense Authorization Act (NDAA) -- which was green-lit by the Republican-led House of Representatives but still needs Senate approval -- is a 14.5 percent pay increase for junior enlisted service members and 4.5 percent for other personnel. But talks over the 1,800-page-plus text were complicated by a last-minute Republican intervention to prevent the military's health program from covering gender-affirming care for children of service members if it results in "sterilization." "Citizens don't want their tax dollars to go to this, and underaged people often regret these surgeries later in life," Nebraska Republican Don Bacon told CNN. "It's a bad hill to die on for Democrats." Gender-affirming health care for children is just one of multiple fronts in the so-called "culture wars" that polarize US politics and divide the country, with Republicans using the issue as a cudgel against Democrats in November's elections. The funding block angered progressives, and prompted the top Democrat on the House Armed Services Committee to come out against the legislation. "As I said a few days ago, blanketly denying health care to people who need it -- just because of a biased notion against transgender people -- is wrong," Adam Smith, who represents a district in Washington state, said in a statement. "The inclusion of this harmful provision puts the lives of children at risk and may force thousands of service members to make the choice of continuing their military service or leaving to ensure their child can get the health care they need." Smith slammed House Speaker Mike Johnson for pandering to "the most extreme elements of his party" by including the transgender provision. The must-pass NDAA -- a bill that Congress has sent to the president's desk without fail every year since 1961 -- cleared the chamber in a 281-140 vote and now moves to the Senate, with final passage expected next week. The topline figure is one percent above last year's total and, with funding from other sources, brings the total defense budget to just under $900 billion. Some foreign policy hawks on the Republican side of the Senate wanted $25 billion more for the Pentagon but they are still expected to support the bill. "The safety and security of the American people is our top priority, and this year's NDAA ensures our military has the resources and the capabilities needed to remain the most powerful fighting force on the planet," Johnson told reporters. ft/mlm'Pretty limited' options for Liberal MPs calling for leadership change
Sami Zayn Says There Were ‘Rumblings’ Of Raw On Netflix Matches Originally Being For WrestleManiaOur community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info Love Island star Sophie Piper has taken to Instagram to address pregnancy rumours with her boyfriend, Joshua Ritchie . Earlier this week, the star, who found love with Josh on the first season of Love Island All Stars took to Instagram to share a number of cute couple pics over the festive season, which she captioned: “Merry Christmas you filthy animals.” In the post, she could be seen having festive fun with Josh wearing a white shirt in front of Christmas lights. In one of the photos, Sophie and Josh could be seen laughing, as fans suspected they saw a ‘bump’ under her shirt, as one commented: “So cute! When is the baby due?” However, another was quick to say: “How can anyone comment ‘when's the baby due’ some people honestly baffle my mind!” It seems the Love Island star saw the comments from fans, as she took to her Instagram story shortly after to post another pic with Josh from the same night. Sharing a post of her leaning on her boyfriend’s shoulder, Sophie penned: "For everyone saying I’m pregnant, I’m not, the wind was blowing up my shirt LOL uncle fester x." Sophie and Josh met last year during the first series of Love Island All-Stars. Originally, Josh starred in season one of the hit show, whilst Sophie took part in the first winter series, which aired in 2020. Sophie spent three weeks in the South African villa during her first stint on the show, while Josh made it to the final in the first season in Mallorca with then-girlfriend Lauren Richardson. The couple then placed third in the 2024 All-Stars series, behind runners-up Callum Jones and Eve Gale and winners Molly Smith and Tom Clare. Since their exit from the show, the couple has been going strong, amassing thousands of fans. A couple of months ago, Sophie’s sister, This Morning presenter Rochelle Humes gushed over their relationship in a chat with Heat . “She’s very happy with him, which I'm very happy about. They're doing well. And she’s really herself with him, I see him loads on FaceTime and she spends quite a lot of time up north,” her famous big sis said. Rochelle then went on to say Sophie was “silly, stupid, playful Sophie with him,” which The Saturdays star said she hadn’t been with others she’d dated in the past. Love Island host Maya Jama will return next month for season two of Love Island All-Stars, which will premiere on January 13 on ITV2.U.S. President-elect Donald Trump has sharply criticized the extension of the national debt ceiling, labeling it as 'one of the dumbest political decisions made in years.' This comes in response to a 2023 budget agreement orchestrated by former House Speaker Kevin McCarthy and President Joe Biden, which suspended the debt limit until January 1, 2025. Trump took to his social media platform, Truth Social, to express his disapproval, stressing that Congress's decision jeopardizes future fiscal stability and insisting that Democrats should be held accountable for any resulting financial turmoil. Trump said, 'The Democrats must be forced to take a vote on this treacherous issue NOW, during the Biden Administration, and not in June.' While the deal allows the U.S. Treasury to honor its financial commitments for several months, the pressing concern is that lawmakers will need to revisit this issue next year to prevent a fiscal crisis. Trump's remarks underscore the contentious political atmosphere surrounding budgetary and fiscal policy debates in Washington. (With inputs from agencies.)
US stocks surge to records, shrugging off upheaval in South Korea, FranceAmarion Dickerson guides Robert Morris past Northern Kentucky 97-93 in triple OT
PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. ( NASDAQ : OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”). Ocean Biomedical is delayed in filing the Form 10-Q as a result of previously disclosed developments with respect to filing of its 10-K for the year ended December 31, 2023. The current notice will have no immediate effect on the listing or trading of Ocean Biomedical’s common stock on Nasdaq, although there can be no assurances that further delays in the filing of the Form 10-Q will not have an impact on the listing or trading of the company’s common stock. On October 16, 2024, Staff notified the Company that since it failed to timely file its Form 10-K for the year ended December 31, 2023, and its Forms 10-Q for the periods ended March 31, 2024 and June 30, 2024, the Company’s securities were subject to delisting. The Company is now delinquent in the filing its form 10-Q for the period ended September 30, 2024. Accordingly, this matter serves as an additional basis for delisting the Company’s securities from The Nasdaq Stock Market. This is formal notification that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market, which hearing is scheduled for December 16, 2024. The Company intends to file the delinquent Forms 10-Q and 10-K as soon as practicable. About Ocean Biomedical Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharma company with an innovative business model that accelerates the development and commercialization of scientifically compelling assets from research universities and medical centers. Ocean Biomedical deploys the funding and expertise to move new therapeutic candidates efficiently from the laboratory to the clinic to the world. Ocean Biomedical is currently developing five promising discoveries that have the potential to achieve life-changing outcomes in lung cancer, brain cancer, pulmonary fibrosis, and the prevention and treatment of malaria. The Ocean Biomedical team is working on solving some of the world’s toughest problems, for the people who need it most. To learn more, visit www.oceanbiomedical.com . Forward-Looking Statements The information included herein and in any oral statements made on behalf of Ocean Biomedical, Inc. (the “Company”) or otherwise in connection herewith include “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, although not all forward-looking statements contain such identifying words. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics and expectations; the expected timing and success of IND filings for our initial product candidates; statements regarding the expected timing of our IND-enabling studies; the frequency and timing of filing additional INDs; expectations regarding the availability and addition of future assets to our pipeline; the advantages of any of our pipeline assets and platforms; the potential benefits of our product candidates; potential commercial opportunities; the timing of key milestones for our programs; the future financial condition, results of operations, business strategy and plans, and objectives of management for future strategy and operations; and statements about industry trends and other companies in the industry. These forward-looking statements are based on various assumptions, whether or not identified herein, and on the current expectations of the Company’s management, and they are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Any discoveries announced by the Company are based solely on laboratory and animal studies. The Company has not conducted any studies that show similar efficacy or safety in humans. There can be no assurances that any treatment tested by the Company will prove safe or effective in humans, and that any clinical benefits of any such treatment is subject to clinical trials and ultimate approval of its use in patients by the FDA. Such approval, if granted, could be years away. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside the control of the Company that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should carefully consider the foregoing factors and the other risks and uncertainties that are described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and other documents filed by the Company from time to time with the SEC and which are and are available at www.sec.gov . These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. We do not undertake any obligation to update any forward-looking statements made by us. These forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this filing. Accordingly, undue reliance should not be placed upon the forward-looking statements. Contacts: Ocean Biomedical Investor Relations connect@oceanbiomedical.com Kevin Kertscher Communications DirectorYear in review: Influential people who died in 2024